IL1B and neoplasm: By studying colorectal cancer patients who received neoadjuvant PD-1 blockade and performing scRNA-seq on their tumor and adjacent normal tissue samples, Li et al. found that myeloid cell subsets were reshaped after ICB treatment, with a significant reduction in the proportion of IL1B+ monocytes cells in pCR patients [43].